# Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

> **NCT00665002** · NA · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 16 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** WT-1
- **DRUG:** Montanide
- **DRUG:** Sargramostim (GM-CSF)

## Key facts

- **NCT ID:** NCT00665002
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-07
- **Final completion:** 2015-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665002, "Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00665002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*